International Opportunities

Careers

International Opportunities

As a world leader in both cancer and infectious-disease research, Fred Hutch is uniquely positioned to address the worldwide cancer epidemic by translating four decades of scientific exploration into new prevention and treatment strategies.

Cape Town & Johannesburg, South Africa

Wembley Square in the City Bowl area of Cape Town is the home of Fred Hutch's lab that opened in 2013

Wembley Square in the City Bowl area of Cape Town is the home of Fred Hutch's lab that opened in 2013

Photo by Robert Hood / Fred Hutch News Service

One of several labs in the 10,000-square-foot research facility that  analyzes blood samples from clinical trial participants throughout the region

One of several labs in the 10,000-square-foot research facility that analyzes blood samples from clinical trial participants throughout the region

Photo by Robert Hood / Fred Hutch News Service

 

Fred Hutch’s lab in Cape Town, South Africa, is one of the most advanced research facilities on the African continent. The 10,000-square-foot lab opened in 2013 and is helping to accelerate groundbreaking efforts by the Fred Hutch–led HIV Vaccine Trials Network (HVTN) to develop an HIV vaccine.

The lab is located in the sparkling Wembley Square development in the City Bowl area, with Table Mountain serving as a dramatic backdrop. It is surrounded by shops, restaurants, and hotels and is within walking distance of many major attractions.

The Cape Town lab analyzes blood samples from clinical trial participants throughout the region and studies how their immune systems interact with the vaccine and with the virus. It also hosts researchers from other countries and trains South African scientists in lab techniques related to diagnosing HIV and AIDS.

The lab currently has a staff of fewer than a dozen people but will grow as clinical trials expand to involve more than 12,000 participants.


Kampala, Uganda

UCI-Fred Hutch Cancer Centre in Kampala, Uganda

The Uganda Cancer Institute-Fred Hutch Cancer Centre in Kampala, Uganda that opened in 2015.

Photo by Robert Hood / Fred Hutch News Service

Lazarus Okoche, PCR Laboratory Manager, dyes tissue samples at UCI - Fred Hutch Cancer Centre in Kampala, Uganda

Lazarus Okoche, PCR Laboratory Manager, dyes tissue samples at UCI - Fred Hutch Cancer Centre in Kampala, Uganda, November 14, 2016.

Photo by Robert Hood / Fred Hutch News Service

 

The world-class UCI-Fred Hutch Cancer Centre in Kampala is the cornerstone of Fred Hutch’s Global Oncology work. Opened in 2015, the three-story, 25,000-square-foot facility can serve up to 20,000 patients a year.

We began collaborating a decade ago with the Uganda Cancer Institute, or UCI, which was — and still is — the only comprehensive cancer facility in a country of more than 37 million people.

The new building features a red-brick exterior that matches the Fred Hutch buildings in Seattle, and is located on the edge of the UCI’s campus. It houses research, training, clinical care and conference facilities and will greatly expand the number of a Ugandan scientists and doctors we can train. Fred Hutch recruits physicians and researchers from other countries to practice and conduct research at the center.

Our research in Uganda focuses on discovering, understanding, and preventing infection-related cancers and diseases. Our researchers in Uganda can collect data from a large number of patients within a single site, which would not be possible in places like the United States, where infection-related cancers are less common and more widely dispersed.